Aruna Kamineni, PhD, MPH, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.
Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.
Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.
Cervical cancer; colorectal cancer; screening; disparities
Electronic clinical and administrative data infrastructure development for research; case-control studies; team science
Croswell JM, Corley DA, Lafata JE, Haas JS, Inadomi JM, Kamineni A, Ritzwoller DP, Vachani A, Zheng Y, National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond 2021 Oct;151:106595. doi: 10.1016/j.ypmed.2021.106595. Epub 2021-06-30. PubMed
Puricelli Perin DM, Christensen T, Burón A, Haas JS, Kamineni A, Pashayan N, Rabeneck L, Smith R, Elfström M, Broeders MJM, International Cancer Screening Network ICSN Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters 2021 Sep doi: 10.1016/j.pmedr.2021.101399. Epub 2021-05-17. PubMed
Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, Dunnewind N, G Campos N, Haas JS, Kobrin S, Kamineni A, Canfell K, Kim JJ Impact of COVID-19-related care disruptions on cervical cancer screening in the United States 2021 Jun;28(2):213-216. doi: 10.1177/09691413211001097. Epub 2021-03-17. PubMed
Kamineni A, Blasi PR, Gundersen GD, Oliver M, Dunn JB, Galloway DA, Madeleine MM Barriers to Human Papillomavirus Vaccine Series Completion among Insured Individuals in an Integrated Healthcare Setting 2021 May 20;14:11786337211018712. doi: 10.1177/11786337211018712. Epub 2021-05-20. PubMed
Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, Kamineni A, Halm EA, Skinner CS, Haas JS, Green BB, Cannizzaro NT, Schneider JL, Corley DA Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems 2020 Nov;13(11):947-958. doi: 10.1158/1940-6207.CAPR-20-0109. Epub 2020-07-15. PubMed
Kamineni A, Vupputuri S Letter to editor: challenges in evaluating diversity and inclusion in scientific communities 2020 Oct;189(10):1210. doi: 10.1093/aje/kwaa115. PubMed
Hua X, Newcomb PA, Chubak J, Malen RC, Ziebell R, Kamineni A, Zhu LC, Upton MP, Wurscher MA, Thomas SS, Newman H, Hardikar S, Burnett-Hartman AN Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia 2020 Jul;31(7):631-640. doi: 10.1007/s10552-020-01304-1. Epub 2020-05-01. PubMed
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium 2020 Mar;112(3):238-246. doi: 10.1093/jnci/djz137. PubMed
Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, Kamineni AS, Schottinger JE, Ghai NR, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Orav EJ, Skinner CS, Halm EA, Corley DA Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population 2020 Mar;158(4):884-894.e5. doi: 10.1053/j.gastro.2019.09.039. Epub 2019-10-04. PubMed
Chen L, Shortreed SM, Easterling T, Cheetham TC, Reynolds K, Avalos LA, Kamineni A, Holt V, Neugebauer R, Akosile M, Nance N, Bider-Canfield Z, Walker RL, Badon SE, Dublin S Identifying hypertension in pregnancy using electronic medical records: The importance of blood pressure values 2020 Jan;19:112-118. doi: 10.1016/j.preghy.2020.01.001. Epub 2020-01-03. PubMed
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Aruna Kamineni, PhD, MPH, discusses her recent study on how guidelines report screening risks.
Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.
Managed Healthcare Executive, Dec. 8, 2022